Literature DB >> 21737035

Current understanding of the pathophysiology of allergic rhinitis.

Lanny J Rosenwasser1.   

Abstract

The immune response to an allergen depends on an initial sensitization process, with future exposures triggering a 2-part allergic response including an early and late phase. The process by which an allergen is recognized has become clearer. Similarly, the roles of the preformed mediators responsible for many of the signs and symptoms of the early-phase response have been elucidated. Recent work also has shed some light on the cells and mediators involved in the late-phase reactions. This article discusses some of this recent work and reviews the basics behind of all of the stages of the allergic response.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21737035     DOI: 10.1016/j.iac.2011.05.009

Source DB:  PubMed          Journal:  Immunol Allergy Clin North Am        ISSN: 0889-8561            Impact factor:   3.479


  16 in total

1.  Azelastine enhances the clinical efficacy of glucocorticoid by modulating MKP-1 expression in allergic rhinitis.

Authors:  Xi Luo; Renqiang Ma; Xingmei Wu; Desheng Xian; Jian Li; Zhonglin Mou; Huabin Li
Journal:  Eur Arch Otorhinolaryngol       Date:  2014-07-25       Impact factor: 2.503

Review 2.  Diagnostic, functional, and therapeutic roles of microRNA in allergic diseases.

Authors:  Thomas X Lu; Marc E Rothenberg
Journal:  J Allergy Clin Immunol       Date:  2013-06-02       Impact factor: 10.793

3.  Effectiveness and safety of ear acupuncture for allergic rhinitis: A protocol of randomized controlled trial.

Authors:  Xiaojun Ding; Shufen Huang; Yajun Tang; Jia Lin
Journal:  Medicine (Baltimore)       Date:  2021-03-26       Impact factor: 1.817

4.  Decreased Serum Epinephrine in Children With Positive Skin Prick Test.

Authors:  Seok-Chan Hong; Jeffrey D Suh; Sochung Chung; Seung-Hoon Lee; Ji Ho Choi; Jeong In Oh; In-Tae Kim; Jin Kook Kim; Jae Hoon Cho
Journal:  Clin Exp Otorhinolaryngol       Date:  2015-11-10       Impact factor: 3.372

5.  Houttuynia cordata Thunb inhibits the production of pro-inflammatory cytokines through inhibition of the NFκB signaling pathway in HMC-1 human mast cells.

Authors:  Hee Joe Lee; Hye-Sook Seo; Gyung-Jun Kim; Chan Yong Jeon; Jong Hyeong Park; Bo-Hyoung Jang; Sun-Ju Park; Yong-Cheol Shin; Seong-Gyu Ko
Journal:  Mol Med Rep       Date:  2013-07-11       Impact factor: 2.952

6.  IL-17 producing T cells correlate with polysensitization but not with bronchial hyperresponsiveness in patients with allergic rhinitis.

Authors:  Vanya M Tsvetkova-Vicheva; Svetla P Gecheva; Regina Komsa-Penkova; Angelika S Velkova; Tcvetan H Lukanov
Journal:  Clin Transl Allergy       Date:  2014-01-15       Impact factor: 5.871

7.  Broncho-Vaxom attenuates allergic airway inflammation by restoring GSK3β-related T regulatory cell insufficiency.

Authors:  Ran Fu; Jian Li; Hua Zhong; Dehong Yu; Xianping Zeng; Mengxia Deng; Yueqi Sun; Weiping Wen; Huabin Li
Journal:  PLoS One       Date:  2014-03-25       Impact factor: 3.240

Review 8.  Respiratory allergies: a general overview of remedies, delivery systems, and the need to progress.

Authors:  Giuliano Molinari; Giselda Colombo; Cinzia Celenza
Journal:  ISRN Allergy       Date:  2014-03-12

9.  Silibinin inhibits the production of pro-inflammatory cytokines through inhibition of NF-κB signaling pathway in HMC-1 human mast cells.

Authors:  Beom-Rak Kim; Hye-Sook Seo; Jin-Mo Ku; Gyung-Jun Kim; Chan Yong Jeon; Jong Hyeong Park; Bo-Hyoung Jang; Sun-Ju Park; Yong-Cheol Shin; Seong-Gyu Ko
Journal:  Inflamm Res       Date:  2013-09-18       Impact factor: 4.575

10.  Correlation between Serum Osteopontin and miR-181a Levels in Allergic Rhinitis Children.

Authors:  Wenlong Liu; Qingxiang Zeng; Renzhong Luo
Journal:  Mediators Inflamm       Date:  2016-04-21       Impact factor: 4.711

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.